Oxcarbazepine-loaded polymeric nanoparticles: Development and permeability studies across in vitro models of the blood–brain barrier and human placental trophoblast

Keyphrases

• In Vitro Model 100%
• Blood-brain Barrier 100%
• Nanoparticles 100%
• Polymeric Nanoparticles 100%
• Extravillous Trophoblast 100%
• Oxcarbazepine 100%
• Permeability Studies 100%
• Nanoencapsulation 40%
• Surfactant 40%
• Poly(lactic-co-glycolic acid) 40%
• Antiepileptic Drugs 40%
• Adverse Effects 20%
• Physical Properties 20%
• Prodrug 20%
• Pregnant Women 20%
• PEGylated 20%
• Fetal Exposure 20%
• Drug Therapy 20%
• Biopolymers 20%
• Fluorescently Labeled 20%
• Transport Studies 20%
• Enhanced Permeability 20%
• Patients with Epilepsy 20%
• Solvent Displacement Method 20%
• Targeted Delivery 20%
• Differential Scanning Calorimetry 20%
• Zeta Potential Value 20%
• Transplacental 20%
• B30.2 20%
• Placental Trophoblast Cells 20%
• Apparent Permeability 20%
• Drug Release Kinetics 20%
• Polydispersity Index 20%
• Rapid Drug Release 20%
• Brain Delivery 20%
• Encapsulated Drugs 20%
• Placental Permeability 20%
• Effciency 20%
• Amorphous State 20%
• X-ray Diffraction Study 20%
• Coated Nanoparticles 20%
• Coumarin 6 20%
• Pregnant Women with Epilepsy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• Oxcarbazepine 100%
• Blood-Brain Barrier 100%
• Anticonvulsive Agent 28%
• Surfactant 28%
• Polyglactin 28%
• Pharmacotherapy 14%
• Prodrug 14%
• Drug Release 14%
• Coumarin 14%
• Differential Scanning Calorimetry 14%
• Zeta Potential 14%
• Resomer 14%